Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease

International Journal of Angiology

Volumn 20, Issue 3, 2011, Pages 149-156

  Neri, Sergio ^a   Signorelli, S S ^a   Scuderi, R ^a   Bruno, M ^a   Bertino, G ^a   Clementi, A ^b   Torrisi, I ^b   Fidone, F ^a   Pagano, A B ^a   Malaguarnera, M ^c   Noto, R ^a  

^a Policlinico di Catania ^*  (Italy)

^b School of Nephrology   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chronic hepatitis; fibrosis; hemodialysis; intima media thickness; nonalcoholic steatohepatitis; oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80053012562     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1283218     Document Type: Article

References (28)

1. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58(1):353-362 (Pubitemid 30429882)
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346(16):1221-1231
3. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122(6):1649-1657 (Pubitemid 34533559)
4. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33(6):1358-1364 (Pubitemid 32496971)
5. Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006;29(6): 1325-1330 (Pubitemid 44125930)
6. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001;12(11): 2458-2464 (Pubitemid 33021124)
7. Nishizawa Y, Shoji T, Maekawa K, et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003;41(3, Suppl 1): S76-S79 (Pubitemid 36278351)
8. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for non alcoholic fatty liver disease. Hepatology 2005;4:1313-1321 (Pubitemid 40770284)
9. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24(1):3-20 (Pubitemid 38496045)
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl 1):S5-S10
11. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43(1):52-58 (Pubitemid 27024390)
12. Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999;145(1):51-60 (Pubitemid 29292700)
13. Yagi K. Assay for serum lipid peroxide level and its chemical significance. In: Yagi K ed. Lipid Peroxides in Biology and Medicine. New York: Academic Press; 1982:223-242
14. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421 (Pubitemid 20279982)
15. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70(1):158-169
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7): 412-419 (Pubitemid 15018832)
17. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20(7):1087-1092 (Pubitemid 27274268)
18. World Health Organization. AUDIT. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Genève, Switzerland: WHO; 1992.
19. O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002;90(10C):18L-21L (Pubitemid 35379900)
20. Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 2006;44(1):197-208 (Pubitemid 41772535)
21. Targher G, Bertolini L, Padovani R, et al. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med 2006;23(4):403-409
22. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007;46(6): 1126-1132 (Pubitemid 46669732)
23. Stenvinkel P, Heimbü rger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55(5):1899-1911 (Pubitemid 29197978)
24. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140(3):167-174
25. Seki S, Kitada T, Sakagushi H, Katani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatol 2002;37(1): 56-62 (Pubitemid 34713055)
26. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99(8):1497-1502 (Pubitemid 39193189)
27. Volzke H, Robinson DM, Kleine V, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005;11(12):1848-1853 (Pubitemid 40520783)
28. Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia 1996; 39(11):1345-1350 (Pubitemid 26356065)